Company / CapEx per Share
IOVANCE BIOTHERAPEUTICS, INC. CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.11
FY2025
5-year range
$0.04 / $244.93
FY2021-FY2025
Trend
+156.5%
vs FY2024
Sector context
#55 of 192
Health Care
What the data says
At $0.11, IOVANCE BIOTHERAPEUTICS, INC.'s capex per share ranks #55 of 192 in the Health Care sector. CapEx per Share returned to growth in FY2025 after 4 years of decline, reaching $0.11.
Based on SEC 10-K filings.
0.11 in FY2025 with a 5-year CAGR of -79.9%.
Declined from $0.12 to $0.11 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -90.5%
- 5-Year CAGR
- -79.9%
- 10-Year CAGR
- -
Sector benchmark
#55 of 192 in Health CareTop 29% of 192This company $0.11 Sector average $2.46
▼
-95.5% below sector average
Key checks
Key Insights
- In FY2025, capex per share increased 156.5% year-over-year.
- Ranks #55 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2020.
- Lowest capex per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.11 | +156.5% |
| FY2024 | $0.04 | -63.6% |
| FY2023 | $0.12 | -99.9% |
| FY2022 | $128.25 | -47.6% |
| FY2021 | $244.93 | -27.6% |
| FY2020 | $338.33 | +508.2% |
| FY2019 | $55.63 | +339655.8% |
| FY2018 | $0.02 | -0.9% |
| FY2017 | $0.02 | -49.6% |
| FY2016 | $0.03 | +8413.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026